Prescription drug overdoses driving death toll
Caitlyn Gribbin: There's a stereotype about drug-related deaths that John Ryan wants to put a stop to.
John Ryan : That idea that it's only illegal drugs is wrong. The overdose toll is actually made up of some people that inject drugs, definitely, but much of the overdose toll is people that are using pharmaceutical drugs, prescription drugs.
Caitlyn Gribbin: John Ryan's the chief executive of the Penington Institute, a not-for-profit drug research group. It's released new research revealing 189 fatal overdoses every four weeks. Proof, Mr Ryan insists, that a new approach is needed to deal with dangerous drug use.
John Ryan : We're losing the equivalent of a Boeing 737 full of Australians every month. The overdose toll has long exceeded the road toll.
Caitlyn Gribbin: Early analysis of the report breaks down the most recent Australian Bureau of Statistics data on drug-induced deaths, which is from 2023. Overdose deaths were down 6% on the previous year, but John Ryan says figures will increase when ABS data revisions come in. The numbers are confronting, with nearly 2,300 people dying of a drug overdose. More than three-quarters were unintentional deaths. Opioids such as heroin and pharmaceutical opioids remain the most common drug type involved in unintentional deaths, contributing to almost half. But the proportion of drug-related fatalities involving stimulants such as methamphetamine and also cocaine increased on previous years.
Amanda Roxburgh : Australia is a major destination for methamphetamine. We've got high numbers of large seizures being detected at our borders.
Caitlyn Gribbin: Amanda Roxburgh, a senior research fellow and clinical psychologist at medical research organisation the Burnet Institute, says the highly potent crystal methamphetamine is the predominant stimulant drug now being used in Australia.
Amanda Roxburgh : We're not only seeing increases in deaths related to methamphetamine, but we're also seeing increases in methamphetamine-related hospitalisations. So it's relatively cheap to buy and it's really readily available.
Caitlyn Gribbin: The Penington analysis also found drug-induced deaths involving stimulants overtook benzodiazepines like Valium as the second most common drug type involved in fatal overdoses. Most drug overdoses are polysubstance overdoses. They involve more than one drug. John Ryan says pharmaceutical opioids such as codeine and oxycodone and those from the benzodiazepine family such as diazepam or Valium are commonly involved in overdose deaths.
John Ryan : The daughter of a friend of mine who went through a messy divorce ended up on benzodiazepines to manage the stress and anxiety and one night drank a bit more red wine than normal, fell asleep on the couch and was found dead the next day. An absolutely tragic example of a middle-aged woman with two young children who died from a combination of prescribed pharmaceuticals and alcohol. Most of these deaths are occurring in private homes and often it's lounge rooms in suburbia and regional and rural towns.
Caitlyn Gribbin: Mr Ryan says only a small amount of funding goes to harm reduction such as overdose education, the opioid overdose reversal drug naloxone, drug testing and safe injecting facilities. A much bigger share goes to law enforcement. The full overdose report will be out this year.
Isabella Higgins: Caitlin Gribbin reporting. In a statement the Federal Department of Health says the National Drug Strategy provides a commitment to harm minimisation through a balanced adoption of evidence-based demand, supply and harm reduction strategies.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


West Australian
35 minutes ago
- West Australian
Australian news and politics live: Independent MP Chaney to introduce Bill to ban AI child sexual abuse apps
Scroll down for the latest news and updates. Independent MP Kate Chaney will today introduce a bill to outlaw technology that assists in the creation of child sexual abuse material. Under the bill it would be an offence to posess AI tools designed for the sole purpose of creating child sexual abuse material. 'This is a clear gap in our Criminal Code that I think we need to be able to respond quickly on so we can make sure we're keeping kids safe,' she said on ABC. 'Currently, possession of these images is illegal, but it's not illegal to possess these particular types of AI tools that are designed for the sole purpose of creating child sexual abuse material. 'So, it means that perpetrators can generate the material using images of real children, delete the images, and then recreate them whenever they want and avoid detection. 'This bill is focused on making it illegal to download these tools that are designed to create this material.' Ms Chaney said action was needed now. 'The challenge that we have is that we're creating a lot of reports and consultations, and the technology is moving so fast, so I think there's a need for urgent action on this. 'We need to be able to plug the gaps as we go, while addressing the broad issues about how we're going to encourage take-up of AI for its productivity benefits but creating appropriate guardrails so that people can have faith in it.'. Australians will pay no more than $25 for selected medicines for the first time in more than 20 years under a proposal to be brought before parliament. It will be the second cap on medicines on the Pharmaceutical Benefits Scheme (PBS) introduced by the Albanese government in three years, after it cut the maximum price of PBS prescriptions from $42.50 to $30. 'The size of your bank balance shouldn't determine the quality of your health care,' Prime Minister Anthony Albanese said. 'My government will continue to deliver cost-of-living relief for all Australians.' PBS medicines would be capped at $7.70 for pensioners and concession card holders until 2030. The bill's introduction is largely a formality, with its passage through the lower house all but assured thanks to Labor's massive 94-seat majority in the 150-seat House of Representatives. Read the story West is best again in economic circles but big gains made on the other side of the Nullarbor have surprised economists and left eastern states languishing. A boost in housing construction has propelled South Australia to second position, above Queensland and Victoria, in CommSec's latest State of the States report released on Monday. Western Australia remains the nation's top performer for the fourth straight quarter with strong returns on retail spending and business investment, but an upheaval could be on the horizon. 'We are seeing Western Australia lose a little bit of momentum,' CommSec chief economist Ryan Felsman told AAP. 'It's been growing at a breakneck speed the last two or three years, and the reason for that is population growth has been the highest for some time.' Read the story A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. 'This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable',' Mr Butler said in a statement. 'For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient.'


SBS Australia
2 hours ago
- SBS Australia
Albanese government moves ahead with election pledge to cap prescription medicines to $25
The Albanese government says it will introduce legislation this week to cap the cost of Pharmaceutical Benefits Scheme (PBS) prescriptions to $25, down from $31.60 from next year. It means the cost of medicines on the PBS could be reduced by over 20 per cent from 1 January, 2026. Pensioners and concession cardholders will continue to pay just $7.70 for their prescriptions until at least 2030. Prime Minister Anthony Albanese said it builds on a pledge for cost of living relief. "The size of your bank balance shouldn't determine the quality of your healthcare," he said. Health Minister Mark Butler said the general patients medicines haven't been this cheap since 2004. In 2024, Australia exported roughly $2.1 billion of medicinal and pharmaceutical products to the United States, Australian Bureau of Statistics data shows. If the US were to put tariffs on medicinal exports, this could make Australian drugs more expensive. Driving down demand could also force manufacturers to move overseas, where the costs of operations are cheaper. The party promised an $8.5 billion boost aimed at strengthening the system and incentivising more clinics to bulk bill. This included $3.5 billion in direct incentives to GPs and medical centres, and $400 million for training more nurses and doctors in primary care settings, outlined in the March federal budget .


SBS Australia
2 hours ago
- SBS Australia
'Hell-bent on trying to give him time': The Australians going overseas for cancer trials
From cosmetic fixes to life-saving surgery, Insight hears from people who have turned to medical tourism. Is it always worth it, and what happens when things go wrong, far from home? Watch Insight episode Medical Tourism Tuesday 29 July at 8.30pm on SBS or live on SBS On Demand . When Hannah Thomas, 32, received a phone call following a routine blood test, she did not expect it would lead to a cancer diagnosis that same week. In 2022, Hannah was diagnosed with T-cell acute lymphoblastic leukaemia (ALL), a type of cancer that affects the blood and bone marrow, where there's an overproduction of immature white blood cells. She was immediately admitted to hospital and underwent chemotherapy five days a week for two months. The chemotherapy did not work but following other treatments, including a bone marrow transplant , Hannah had no traces of cancer in her body a year later. However, shortly after Hannah married in 2023, the cancer came back. She and her husband, Simon, met with Hannah's haematologist and were introduced to the concept of CAR T-cell therapy, a form of immunotherapy that uses a patient's own genetically modified T-cells (a type of white blood cell). This experimental cancer treatment is offered in Australia for the more common B-cell type of ALL but is not currently offered as standard treatment for T-cell ALL. But Hannah didn't qualify for the clinical trials in Melbourne and London, so she and Simon decided to seek the treatment in Singapore. Hannah and Simon married in 2023, shortly before her cancer came back. Source: Supplied The Sydney couple had less than 24 hours to figure out how they were going to pay for the costs of the trial and accommodation, which they estimated to be around $400,000. The couple immediately investigated loans and started the application process to withdraw their superannuation. "In the end, the only reason we were able to catch that flight and go there was because one of our closest friends Dan set up a GoFundMe for us," Hannah told Insight. "Though it's hard not to feel a bit guilty. And I think it's only natural to wonder if you're worthy of all that." Seeking options abroad Like Hannah and Simon, Dianne Mehmet turned to Asia for experimental cancer treatment when options in Australia became limited. Dianne's son Jordan had just finished high school in 2013 when he was diagnosed with Ewing sarcoma — a rare, aggressive cancerous tumour that affects bones and soft tissue. The 18-year-old went through three years of intensive treatment, including radiotherapy, chemotherapy and surgery to remove tumours in his body. However, his condition worsened. Feeling like there was nothing more their medical team could do in Australia, Dianne was desperate to take her son anywhere that might give him a chance to live longer. "With Ewing sarcoma, most people do not live past five years … but I just was hell-bent on trying to give him time," Dianne said. Dianne took her son Jordan to China for experimental cancer treatment. Source: Supplied After hearing about a friend's positive experience, Dianne took Jordan to China in 2016, where he continued conventional treatment for cancer but with the addition of natural therapy. To afford the cost of overseas accommodation and the $100,000 treatment, Dianne remortgaged the family home and crowdfunded with support from their local community. "I didn't want Jordan to think for one more minute, 'What am I going to do?' and have it hanging over his head." Medical tourism's rising popularity Nine years on from when Dianne and Jordan sought treatment overseas, medical tourism continues to grow in popularity. Before the COVID-19 pandemic, roughly 15,000 Australians went on self-funded medical tourism trips each year, according to a 2022 Victoria University thesis. Cosmetic surgery, dentistry, heart surgery, fertility treatments, gender-affirming surgery, stem-cell therapy and cancer treatments are the most common medical reasons Australians go abroad. "We have a world-class health system in Australia, but it can't do everything for everyone at all times," Dr Michael Bonning told Insight. The general physician and Australian Medical Association (NSW) president says that, in addition to the unavailability of certain treatments in Australia, saving money also motivates many to participate in medical tourism. "Sometimes it is because of access; we just don't do some of these procedures. And the second part is sometimes because of cost." But seeking treatment overseas is riskier than sticking with Australia's highly regulated health system, he warns. "When you go overseas, you open yourself up to other challenges [such as] language barriers. Sometimes we also see the standards of care are not the same as we would expect here." The cost and personal toll of travel were two other factors people considering medical tourism should take into account, he added. 'A single purpose' Hannah and Simon lived in Singapore for five months while Hannah participated in the clinical trial. They celebrated Christmas, New Year and Hannah's 32nd birthday while she was in hospital. Simon said that there were many dark times for him during those five months but "obviously nothing compared to what Hannah was going through". "What made it simple for me was having a single purpose ... to look after Hannah, make sure she was comfortable and got the treatment that she needed," Simon said. "And ultimately to get her better and bring her back." Hannah received treatment at a Singapore hospital. Source: Supplied Upon completion of the trial, Hannah was discharged with no detectable cancer cells. They returned to Sydney where, after a second bone marrow transplant, the good news was confirmed again. "I'm in remission and I have been for the last 15 months, but I say that with caution because we still have tests every eight weeks … to check and see if the cancer is coming back." The impact of overseas treatment For Dianne's son Jordan, things appeared to be improving with the "amazing" Chinese medical team working with him. "He was going very well at the start … he felt 100 per cent supported." However, Jordan started to behave unusually towards the end of their three-month stay. Doctors then discovered he had brain swelling due to a growing tumour. After emergency surgery and changes to his treatment while in operation recovery, Jordan's cancer continued to metastasise. Although overseas treatment didn't wholly work for Jordan, Dianne doesn't regret her attempt to give her son a longer life. Source: Supplied The family returned home to Melbourne in October 2016 where Jordan died three months later at the age of 22. Dianne says she would have liked for all of Jordan's treatment to have taken place in Australia if more could have been done to save her son. "If you have to travel overseas for treatment, your life is disrupted in so many ways. And it's not just you, it's the impact on your family [and] your friends," she says. "You're living in a place where you don't speak the language, you're totally out of your comfort zone. You can't have all your support there." Although the treatment did not wholly work for Jordan, Dianne does not regret taking him overseas for experimental treatment. "He was happy, and he always had hope. "I wanted him to have hope right up till the last minute."